FACIAL ENHANCEMENT SUITE LIMITEDActive

Company number 11008352Private limited companyIncorporated 2017

Key figures

£493,727+268.1%
Net assets 2024/25
+18.3%
Average annual growth 2019/20–2024/25
-500 k0500 k1 m2019/202020/212021/222022/232023/242024/25

Like most small UK companies, FACIAL ENHANCEMENT SUITE LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0500 k1 m1.5 m2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand—741,847909,748251,037—
Total assets547,528903,6191,071,520412,809170,974
Total liabilities223,474174,051207,222706,566664,701
Net assets / total equity324,054729,568864,298-293,757493,727
Average number of employees41010127

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: FACIAL ENHANCEMENT SUITE LIMITED

Company

FACIAL ENHANCEMENT SUITE LIMITED is a private limited company registered with Companies House under company number 11008352. It was incorporated on 11 Oct 2017. Its status is active. The registered office is in Leeds (LS9). Its nature of business (SIC 2007) is other human health activities (86900).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 Mar 2025); the company files micro-entity accounts. Net assets were £493,727, up 268.1% on the previous year. Total assets were £170,974 and total liabilities £664,701. The company had an average of 7 employees. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

One person with significant control is registered. 1 of 1 registered charges are outstanding.

Filing deadlines

The next accounts are due by 31 Dec 2026. The next confirmation statement is due by 30 May 2027.